Month: June 2021

Submission supported by previously announced data from Phase 3 MPOWERED™ study NEEDHAM, Mass., June 28, 2021 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases currently treated with burdensome and painful injections, today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval of MYCAPSSA® (oral octreotide capsules) as a maintenance therapy for adults with acromegaly. The MAA is supported by positive results from Chiasma’s global Phase 3 MPOWERED™ non-inferiority clinical trial comparing MYCAPSSA to long-acting injectable somatostatin analogs...

SOUTH SAN FRANCISCO, Calif., June 28, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS) today announced that it has commenced an underwritten public offering of 4,000,000 shares of common stock. In addition, Aligos intends to grant the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock. All of the shares of common stock are being offered by Aligos. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. J.P. Morgan, Jefferies and Piper Sandler are acting as the joint book-running managers for the offering. Cantor is acting as a lead manager for the offering. A registration statement relating to these securities has been filed with the Securities...

Company announcement – No. 42/ 2021 ZEALAND PHARMA A/S – SHARE BUY-BACK PROGRAM UNDER SAFE HARBOUR TO AQUIRE DANISH COMMON STOCK FOR EMPLOYEE INCENTIVE PROGRAMS On 29 June 2021, Zealand Pharma A/S (“Zealand”) will initiate a share repurchase program in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbor Regulation”).  Zealand has entered an arrangement with Danske Bank A/S to act as exclusive manager under the program. Danske Bank A/S will buy back shares on behalf of Zealand and make related trading decisions independently of and without influence by Zealand. The share repurchase program will be implemented under the following terms:The maximum total consideration for...

CAMBRIDGE, Mass., June 28, 2021 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, is pleased to announce that Garett Kitch has joined as Senior Vice President of Health and Life Agency Sales. “Garett is an accomplished sales leader with a track record of rapidly scaling teams of agents to support significant organizational growth. His deep industry experience and data-driven sales management expertise fit exceptionally well with our culture,” said GM of Health and Life, Tom McDermott. “Garett’s proven leadership skills will further accelerate the growth of our Health and Life insurance verticals by creating a world class first-party sales organization and I’m thrilled to welcome him to our team.” “EverQuote has built a strong culture of collaboration, employee empowerment and innovation...

New Orders Signal Strength of Recovery in Commercial Markets FREMONT, Calif., June 28, 2021 (GLOBE NEWSWIRE) —  Identiv, Inc. (NASDAQ: INVE), a global leader in digital security and identification, today announced new orders received from Banco Azteca and Ross Stores, demonstrating renewed growth among commercial customers within its Premises segment. During May and June, Identiv recognized over $1.1 million in software license revenue for orders from Banco Azteca, part of Grupo Elektra and one of the largest banking and retail businesses in Mexico. Identiv enabled Banco Azteca to expand its existing video and data analytics solutions across more than 400 additional stores providing real-time intelligence designed to make security operations smarter and more scalable. Banco Azteca continued the rollout of Identiv’s solution, which...

Xian, China, June 28, 2021 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the closing of its previously announced firm commitment initial public offering of 2,200,000 ordinary shares, par value US$0.0001 per share (the “Shares”) at a public offering price of $5.00 per Share (the “Offering”), for total gross proceeds of $11.0 million, before deducting underwriting discounts, commissions and other related expenses. In addition, BON has granted the underwriters a 45-day option to purchase up to an additional 330,000 Shares at the public offering price, less underwriting discount and commissions. The Shares began trading on the Nasdaq Capital Market under...

FITCHBURG, Mass., June 28, 2021 (GLOBE NEWSWIRE) — Micron Solutions, Inc. (OTCQB: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, Inc., producing highly-engineered, innovative components requiring precision machining and injection molding, announced that Wayne Coll, Chief Financial Officer, Treasurer and Secretary, will be leaving the Company on July 16, 2021. The Company thanks Mr. Coll for his many significant contributions to the Company over the past two years, including the recently closed sale-lease back transaction and updates to the Company’s business reporting and systems. CEO Bill Laursen commented, “Wayne’s leadership and successful efforts in enhancing our business reporting and systems, and the recent completion of the sales-lease back...

BOSTON and JERUSALEM, June 28, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced it will conduct a conference call to discuss results from its successfully completed Phase 2 clinical trial of EB613 for the treatment of osteoporosis. EB613 is an oral formulation of human parathyroid hormone (1-34), or PTH, and is positioned to be the first oral bone building (anabolic) product to treat osteoporosis patients. Attendees on the call will include osteoporosis expert and Principal Investigator of the Phase 2 study Dr. Liana Tripto-Shkolnik, Sheba Medical Center, Institute of Endocrinology. Dr. Tripto-Shkolnik will provide context on the results of the study and the benefits of an oral drug to treat osteoporosis. Also on the call will be...

Thousand Oaks, CA, June 28, 2021 (GLOBE NEWSWIRE) — CBDual Biotechnology Corp’s parent company, THC Farmaceuticals, Inc (OTC: CBDG), developer of a unique line of premium CBD based oral health products as well as Dr. Rubin’s Anxiety Pills today announced the final departure of CBDG’s Chairman and CEO. Senator Mike Gravel, former CEO of THC Farmaceuticals, Inc (OTC: CBDG), who in his own words “brought judgment to the table based upon experience and accomplishment,” sadly departed from his family home in California this weekend. “Senator Gravel’s wealth of experience with public policies, politics and private business made him the best candidate for CEO, and helped ­­­­­­­­­­­­­CBDG and the entire cannabis sector’s efforts to overcome federal criminalization policies,” said Company...